Discover 928 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 928
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Salem OR, Olympia WA, Boise ID, Carson City NV,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Using EMA Data to Inform a Web-intervention for Couples Concerned About Drinking
for
Alcohol; Use, Problem
Location: Portland OR
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT06501677
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Portland OR, Seattle WA, San Francisco CA,
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06858579
Phase 3, Recruiting
Promoting Math in Young Children: Leveraging Pediatric Clinics to Reach Underrepresented Children in Rural Communities
for
Early Math Learning
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 3 - 4
Code: NCT05884541
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for
Non-Small Cell Lung Cancer
Location: Portland OR, Vancouver WA, Eugene OR, Seattle WA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT06767514
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Portland OR, Vancouver WA, Olympia WA, Seattle WA,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07085767
Phase 3, Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: Portland OR, Mill Creek WA, Medford OR, Surrey, Nanaimo,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase 3, Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Implementation of Problem-Solving Treatment in Community Health Centers (PST-Aid)
for
Depression
Location: Portland OR
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06494384
Recruiting
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
for
Tumor Hyperinsulinism (Tumor HI)
Location: Portland OR, Rochester MN, Chicago IL, Houston TX,
Sponsor: Rezolute
Sex: All
Age: 18+
Code: NCT06881992
Phase 3, Recruiting
Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
for
Opioid Use Disorder
Location: Portland OR
Sponsor: Boulder Care
Sex: All
Age: 18+
Code: NCT07169409
Phase 1, Recruiting
MORE in the Management of Lumbosacral Radiculopathy Symptoms: A Randomized Controlled Trial
for
Lumbar Radiculopathy
Location: Portland OR
Sponsor: National University of Natural Medicine
Sex: All
Age: 18 - 65
Code: NCT04818606
Recruiting
Zypan Functional Dyspepsia
for
Dyspepsia
Location: Portland OR
Sponsor: National University of Natural Medicine
Sex: All
Age: 18 - 70
Code: NCT06320379
Recruiting
Prospective Observational Study of Naturopathic Approaches to IBS
for
Irritable Bowel Syndrome (IBS)
Location: Portland OR
Sponsor: National University of Natural Medicine
Sex: All
Age: 18+
Code: NCT06721624
Recruiting
Herbal Evaluation Of Artemisia Annua For Small Intestinal Bacterial Overgrowth
for
Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
Location: Portland OR
Sponsor: National University of Natural Medicine
Sex: All
Age: 18+
Code: NCT06721884
Phase 1, Phase 2, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Fruitland ID, Post Falls ID, Coeur d'Alene ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Portland OR, Vancouver WA, Clackamas OR, Tualatin OR,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase 3, Recruiting
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa (HS)
Location: Portland OR, Surrey, Los Angeles CA, Fountain Valley CA,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07783542
Phase 2, Recruiting
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis